Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-02-07

Clinical Trial Update: Prevention of Secondary Hyperparathyroidism With Vitamin D in Stage II/III Chronic Kidney Disease [NA]

View source ↗

Summary

Completed clinical trial evaluating whether vitamin D can prevent secondary hyperparathyroidism in patients with stage II/III chronic kidney disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Vitamin D (Cholecalciferol)

Snippet

Sponsor: Atlanta VA Medical Center | Conditions: Kidney Disease | NA | Status: COMPLETED